Substance-Related Disorders
Welcome,         Profile    Billing    Logout  
 70 Companies   97 Products   97 Products   124 Mechanisms of Action   1 Trial   1962 News 


«12...28293031323334353637383940»
  • ||||||||||  Enrollment change:  LGBT Internet Based Smoking Treatment - 1 (clinicaltrials.gov) -  Jun 24, 2012   
    P3,  N=792, Completed, 
    N=600 --> 792
  • ||||||||||  Trial completion:  Intensive Intervention for Smokers - 6 (clinicaltrials.gov) -  Jun 24, 2012   
    P2/3,  N=162, Completed, 
    N=600 --> 792 Not yet recruiting --> Completed
  • ||||||||||  Trial completion:  LGBT Internet Based Smoking Treatment - 1 (clinicaltrials.gov) -  Jun 24, 2012   
    P3,  N=792, Completed, 
    Not yet recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  bupropion sustained-release / Generic mfg.
    Trial completion:  Maintaining Nonsmoking: Older Smokers - 1 (clinicaltrials.gov) -  Jun 17, 2012   
    P3,  N=403, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Twinrix (inactivated hepatitis A and recombinant hepatitis B) / GSK, Engerix-B (hepatitis B vaccine recombinant) / GSK
    Trial completion, Adherence:  UFO VAX: A Randomized Trial of Vaccine Adherence in Young Injection Drug Users (clinicaltrials.gov) -  Jun 13, 2012   
    P=N/A,  N=546, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed
  • ||||||||||  New P2 trial:  ABT-436 for Alcohol Dependence (clinicaltrials.gov) -  Jun 4, 2012   
    P2,  N=148, Recruiting, 
  • ||||||||||  Chantix (varenicline) / Pfizer
    Trial completion:  Relapse Prevention With Varenicline (clinicaltrials.gov) -  May 30, 2012   
    P4,  N=120, Completed, 
    Recruiting --> Completed Recruiting --> Completed
  • ||||||||||  Enrollment closed:  Vigabatrin for the Treatment of Cocaine Dependency (clinicaltrials.gov) -  May 9, 2012   
    P2/3,  N=200, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion:  Vigabatrin for Treatment of Cocaine Dependence (clinicaltrials.gov) -  May 9, 2012   
    P2,  N=186, Completed, 
    Recruiting --> Active, not recruiting Active, not recruiting --> Completed
  • ||||||||||  Trial termination:  First in Humans Study of JDTic (clinicaltrials.gov) -  May 8, 2012   
    P1,  N=24, Terminated, 
    Active, not recruiting --> Completed Active, not recruiting --> Terminated; No further subjects will be enrolled due to adverse events.
  • ||||||||||  zonisamide / Generic mfg.
    Enrollment open:  Zonisamide for Heavy Drinkers With Bipolar Disorder (clinicaltrials.gov) -  May 8, 2012   
    P2,  N=40, Recruiting, 
    Active, not recruiting --> Terminated; No further subjects will be enrolled due to adverse events. Not yet recruiting --> Recruiting
  • ||||||||||  Trial initiation date:  VIDA: Validating Interventions for Diverse Adolescents (clinicaltrials.gov) -  Apr 28, 2012   
    P2,  N=70, Completed, 
    Active, not recruiting --> Completed Initiation date: Aug 2009 --> Jun 2010
  • ||||||||||  Enrollment change:  Prize Reinforcement for Smoking Cessation (clinicaltrials.gov) -  Apr 25, 2012   
    P=N/A,  N=84, Completed, 
    N=36 --> 70 N=110 --> 84
  • ||||||||||  Trial completion:  Prize Reinforcement for Smoking Cessation (clinicaltrials.gov) -  Apr 25, 2012   
    P=N/A,  N=84, Completed, 
    Recruiting --> Completed Recruiting --> Completed
  • ||||||||||  Trial completion:  Substance Abuse and Trauma in Incarcerated Women (clinicaltrials.gov) -  Apr 24, 2012   
    P=N/A,  N=95, Completed, 
    N=9012011 --> 360 Active, not recruiting --> Completed
  • ||||||||||  Ryzolt (abuse resistant formulation) / Endo
    Enrollment open:  Medications Development for Drug Abuse Disorders (clinicaltrials.gov) -  Apr 19, 2012   
    P1/2,  N=150, Recruiting, 
    Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
  • ||||||||||  buprenorphine/naloxone sublingual film / Generic mfg., buprenorphine sublingual tablets / Generic mfg.
    New P2 trial:  Transfer of Subjects From Subutex/Suboxone to RBP-6300 (clinicaltrials.gov) -  Apr 18, 2012   
    P2,  N=143, Active, not recruiting,